700 patients110,866 observations180 daysLIVE

Patient P-02415

Synthetic patientMETA-24 · Day 146 · 65–74 · F · baseline S17Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S17
  2. Day 97 GI-04 recommendedGI Support Protocol GI-04
  3. Day 98 Patient acceptedStarted GI-04 in the companion
  4. Day 106 GI symptom burden −11% vs expectedGI Support Protocol GI-04
  5. Day 112 Tolerance state changedUnstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Inflammatory activity+8
  • Toxicity+8
  • Treatment adherence-7
  • GI instability+3
  • Nutritional resilience+3

What helped?

  • GI Support Protocol GI-04Day 97
    Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
38 min
worsening · -1.3 vs previous 14 d
Sleep duration
Wearable
7.5 h
stable · -0.1 vs previous 14 d
Energy level
Daily log
5.9/10
stable · +0.1 vs previous 14 d
Steps
Wearable
3,486
worsening · -206 vs previous 14 d
GI burden
Companion
21.4/100
stable · -0.3 vs previous 14 d
Adherence
Companion
90.3 %
stable · +0.7 vs previous 14 d
Sleep quality
Wearable
46.4/100
stable · -1.0 vs previous 14 d
Glucose, CGM daily mean
CGM
122 mg/dL
stable · +4.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 87 from the failing basin, 10 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -3.9 next day on high-intake days · n 20
Would not help
  • Keep caffeine low
    GI +4.5 next day on high-intake days · n 20
  • Keep simple carbs low
    GI +4 next day on high-intake days · n 20
  • Keep histamine low
    GI +3.6 next day on high-intake days · n 21
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Caffeine
    +4.5detractor · 95%
  • Simple carbohydrates
    +4detractor · 95%
  • Protein
    -3.9supporter · 95%
  • Histamine load
    +3.6detractor · 95%
  • Ultra-processed food
    +2.6detractor · 69%
  • Insoluble fibre
    +0.8no signal · 19%
  • Dietary fat load
    -0.5no signal · 15%
  • Alcohol
    +0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Drug metabolism and exposure 40
    • DNACYP2D6 poor metabolizer → higher exposure
  • Inflammatory signalling 35
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 35 ms, trending down
  • Mucosal barrier integrity 30
    • DNAFUT2 non-secretor lowers mucosal fucosylation
  • Autonomic recovery 20
    • Wearable3,486 steps/day
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.8 · butyrate capacity 61/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
35 ms
Sleep
7.4 h
Steps
3,113
Resting HR
58 bpm
Daily log: GI score 21, nutritional resilience 71, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0208154%S20DT-01no change88
P-0267254%S0987
P-0200753%S0885
P-0231953%S0689
P-0238453%S1080
P-0245653%S2086
P-0230452%S1592
P-0210451%S1594
P-0225651%S1685
P-0239351%S1980
P-0240251%S0588
P-0243151%S1682